In this episode, John D’Angelo, MD, President and CEO of Northwell Health, discusses a fundamentally different approach to treating rheumatoid arthritis (RA): bioelectronic medicine, which uses the body’s own nervous system to help regulate the inflammation that drives the disease. Delivered by a small implanted medical device that stimulates the vagus nerve, the FDA-approved therapy offers an alternative to costly medications that can also cause significant side effects or fail to provide adequate relief.
Northwell Health was the first health system to build a clinical program around the therapy, which builds on decades of pioneering research at its Feinstein Institutes. Dr. D’Angelo discusses what this new therapeutic category could mean for people living with RA and, more broadly, the future of autoimmune care.
